REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilab, Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing
Full name: Unilab, Inc. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Unilab, Inc. is a company based in Philippines, with its head office in Mandaluyong. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on September 12, 1955. Unilab, Inc. currently employs 4,000 (estimated) people. In its most recent financial highlights, the company reported a net sales revenue increase of 0.73% in 2024. Its’ total assets recorded a growth of 14.71%. In 2024, Unilab, Inc.’s net profit margin increased by 0.43%.

Headquarters
No. 66 United Street, Barangay Highway Hills
Mandaluyong; National Capital Region; Postal Code: 1550

Contact Details: Purchase the Unilab, Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Unilab, Inc. report to view the information.
Financial Auditors:
Purchase the Unilab, Inc. report to view the information.
Incorporation Date:
September 12, 1955
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Amherst Laboratories, Inc.
Amherst Parenterals, Inc.
Company Performance
Financial values in the chart are available after Unilab, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
0.73%
Total Operating Revenue
1.53%
Operating Profit
2.97%
EBITDA
2.97%
Net Profit/Loss for the Period
3.17%
Total Assets
14.71%
Total Equity
27.84%
Operating Profit Margin
0.53%
Net Profit Margin
0.43%
Return on Equity (ROE)
-5.42%
Debt / Equity
-6.17%
Quick Ratio
0.92%
Cash Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?